Renalytix Stock Analysis


USD 1.28  0.01  0.78%   

The big decline in price over the last few months for Renalytix AI Plc created some momentum for investors as it was traded today as low as 1.24 and as high as 1.32 per share. The company directors and management failed to add value to investors and position the company supply of money to exploit market volatility in August. However, diversifying your holdings with Renalytix AI Plc or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.67. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Renalytix partners.
Additionally, take a look at Your Equity Center.
The Renalytix stock analysis report makes it easy to digest most publicly released information about Renalytix and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Renalytix Stock analysis module also helps to analyze the Renalytix price relationship with some important fundamental indicators such as market cap and management efficiency.

Renalytix Stock Analysis Notes

About 18.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.79. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Renalytix AI Plc recorded a loss per share of 1.04. The entity had not issued any dividends in recent years. Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York. Renalytix operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people. To find out more about Renalytix AI Plc contact the company at 646 397 3970 or learn more at

Renalytix AI Plc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Renalytix's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Renalytix AI Plc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Renalytix AI Plc generated a negative expected return over the last 90 days
Renalytix AI Plc may become a speculative penny stock
Renalytix AI Plc has high historical volatility and very poor performance
The company reported the previous year's revenue of 2.61 M. Net Loss for the year was (49.94 M) with profit before overhead, payroll, taxes, and interest of 633 K.
Renalytix AI Plc currently holds about 32.36 M in cash with (36.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89.

Renalytix Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Renalytix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Renalytix AI Plc backward and forwards among themselves. Renalytix's institutional investor refers to the entity that pools money to purchase Renalytix's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Gilder Gagnon Howe Co LlcCommon Shares1.6 M3.8 M
Philosophy Capital Management LlcCommon Shares858.7 K2.1 M
Gwk Investment Management LlcCommon Shares566.5 K1.4 M
Parian Global Management LpCommon Shares395.9 K970 K
Pinnacle Associates LtdCommon Shares340.2 K834 K
Granahan Investment Management LlcCommon Shares324.2 K794 K
Fred Alger Management LlcCommon Shares307.6 K754 K
Note, although Renalytix's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Renalytix Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 51.07 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Renalytix's market, we take the total number of its shares issued and multiply it by Renalytix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (48.34) % which means that it has lost $48.34 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (91.27) %, meaning that it created substantial loss on money invested by shareholders. Renalytix management efficiency ratios could be used to measure how well renalytix ai plc manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 30th of September, Renalytix holds the risk adjusted performance of (0.28), and Coefficient Of Variation of (400.26). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Renalytix, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Renalytix AI Plc, which can be compared to its competitors. Please check Renalytix AI Plc variance and potential upside to decide if Renalytix AI Plc is priced some-what accurately, providing market reflects its current price of 1.28 per share. Given that Renalytix is a hitting penny stock territory we advise to closely look at its total risk alpha.

Renalytix AI Plc Price Movement Analysis

The output start index for this execution was thirty with a total number of output elements of thirty-one. The Moving Average is predictive technique used to analyze Renalytix AI Plc price data points by creating a series of averages of different subsets of Renalytix entire price series.

Renalytix Predictive Daily Indicators

Renalytix intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Renalytix stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Renalytix Forecast Models

Renalytix time-series forecasting models is one of many Renalytix's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Renalytix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Renalytix Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Renalytix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Renalytix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Renalytix. By using and applying Renalytix Stock analysis, traders can create a robust methodology for identifying Renalytix entry and exit points for their positions.
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York. Renalytix operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Renalytix to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Optimization Now


Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Module
Additionally, take a look at Your Equity Center. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for analysis

When running Renalytix AI Plc price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Is Renalytix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Renalytix. If investors know Renalytix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Renalytix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Renalytix AI Plc is measured differently than its book value, which is the value of Renalytix that is recorded on the company's balance sheet. Investors also form their own opinion of Renalytix's value that differs from its market value or its book value, called intrinsic value, which is Renalytix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Renalytix's market value can be influenced by many factors that don't directly affect Renalytix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Renalytix's value and its price as these two are different measures arrived at by different means. Investors typically determine Renalytix value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Renalytix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.